WHO ICTRP trial
Methodology Study to develop Sinerem enhanced 3T MR Imaging of Atherosclerotic…
EUCTR2008-005288-33-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-005288-33-GB |
|---|---|
| Public title | Methodology Study to develop Sinerem enhanced 3T MR Imaging of Atherosclerotic Plaques within the Carotid Arteries, and to compare Sinerem MRI to contrast enhanced ultrasound |
| Scientific title | Methodology Study to develop Sinerem enhanced 3T MR Imaging of Atherosclerotic Plaques within the Carotid Arteries, and to compare Sinerem MRI to contrast enhanced ultrasound |
| Primary sponsor | GlaxoSmithKline Research & Development, LtdD |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom |
| Conditions | Atherosclerotic plaque within the carotid artery. MedDRA version: 9.1 Level: LLT Classification code 10051615 Term: Atherosclerotic cardiovascular disease |
| Interventions | Product Name: Sinerem Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: Ferumoxtran-10 (USAN) Concentration unit: g gram(s) Concentration type: equal Concentration number: 1.0- INN or Proposed INN: Ferumoxtran-10… |
| Registration date | Jan 19, 2009 |
| Secondary IDs | EMI111784 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: